Results 31 to 40 of about 477,501 (260)

Cardiovascular disease in SARS‐CoV‐2 infection

Clinical & Translational Immunology, 2021
Pre‐existing cardiovascular disease (CVD) increases the morbidity and mortality of COVID‐19 and is strongly associated with poor disease outcomes. However, SARS‐CoV‐2 infection can also trigger de novo acute and chronic cardiovascular disease.
Kei Sato, Jane E Sinclair, Habib Sadeghirad, John F Fraser, Kirsty R Short, Arutha Kulasinghe   +5 more
doaj   +1 more source

Evolutionary Dynamics and Dissemination Pattern of the SARS-CoV-2 Lineage B.1.1.33 During the Early Pandemic Phase in Brazil

Frontiers in Microbiology, 2021
A previous study demonstrates that most of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) Brazilian strains fell in three local clades that were introduced from Europe around late February 2020.
Paola Cristina Resende, Edson Delatorre, Tiago Gräf, Daiana Mir, Fernando Couto Motta, Luciana Reis Appolinario, Anna Carolina Dias da Paixão, Ana Carolina da Fonseca Mendonça, Maria Ogrzewalska, Braulia Caetano, Gabriel Luz Wallau, Cássia Docena, Mirleide Cordeiro dos Santos, Jessylene de Almeida Ferreira, Edivaldo Costa Sousa Junior, Sandro Patroca da Silva, Sandra Bianchini Fernandes, Lucas Alves Vianna, Larissa da Costa Souza, Jean F. G. Ferro, Vanessa B. Nardy, Cliomar A. Santos, Irina Riediger, Maria do Carmo Debur, Júlio Croda, Júlio Croda, Wanderson K. Oliveira, André Abreu, Gonzalo Bello, Marilda M. Siqueira   +29 more
doaj   +1 more source

Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2

Advanced Science, 2020
The world is currently experiencing a global pandemic caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which causes severe respiratory disease similar to SARS.
Yetian Dong, Tong Dai, Jun Liu, Long Zhang, Fangfang Zhou   +4 more
doaj   +1 more source

Racing for a SARS‐CoV‐2 vaccine

EMBO Molecular Medicine, 2021
Graphical Abstract Interview with EMBO Members Özlem Türeci and Uğur Şahin, BioNTech, conducted by science journalist Kai Kupferschmidt.
Özlem Türeci, Uğur Şahin
doaj   +1 more source

Subacute thyroiditis after SARS‐CoV‐2 infection

Clinical Case Reports, 2021
Viral infections are considered as etiologic factors of subacute thyroiditis. The true incidence of subacute thyroiditis, caused by SARS‐CoV‐2 infection, is probably considerable since it is often masked by more dramatic affection of the respiratory ...
Vasiliy I. Semikov, Davit L. Aghayan, Alexander M. Shulutko, Tatyana V. Khorobrykh, Yuriy K. Aleksandrov, Gaukhar T. Mansurova, Airazat M. Kazaryan   +6 more
doaj   +1 more source

Radiographic findings of SARS‐CoV‐2 infection

Journal of the American College of Emergency Physicians Open, 2021
Study objective The 2019–20 coronavirus pandemic is caused by the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which causes coronavirus disease 2019 (COVID‐19).
Catherine A. Marco, Steven J. Repas, Haely Studebaker, Nancy Buderer, Joseph Burkhammer, Jonathan Shecter, Amanda Hinton, J. Michael Ballester, John Paul Angeles, Benjamin Kleeman   +9 more
doaj   +1 more source

Maternal SARS‐CoV‐2 infection: The potential vertical transmission of SARS‐CoV‐2 and impact on neonates: A review

Pediatric Discovery, 2023
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), a large, lipid‐enveloped, single‐stranded RNA virus, is a highly contagious virus that caused coronavirus disease 2019 (COVID‐19), declared a pandemic by the World Health Organization on March
Wei Xia, Zhoujie Peng
doaj   +1 more source

SARS-CoV-2 and the Nucleus

International Journal of Biological Sciences, 2022
The ongoing COVID-19 pandemic is caused by an RNA virus, SARS-CoV-2. The genome of SARS-CoV-2 lacks a nuclear phase in its life cycle and is replicated in the cytoplasm. However, interfering with nuclear trafficking using pharmacological inhibitors greatly reduces virus infection and virus replication of other coronaviruses is blocked in enucleated ...
Chen, Mengqi, Ma, Yue, Chang, Wakam
openaire   +2 more sources

Therapeutic antibodies under development for SARS‐CoV‐2

View, 2022
The world is experiencing one of the most difficult moments in history with COVID‐19, which has rapidly developed into a worldwide pandemic with a significant health and economic burden.
Zetong Ma, MengMei Zhu, Shuyi Zhang, Kewen Qian, Chuqi Wang, Wenyan Fu, Changhai Lei, Shi Hu   +7 more
doaj   +1 more source

SARS-CoV-2 and the kidney

Australian Journal of General Practice, 2021
COVID-19 has been at the forefront of public and scientific attention since the initial report in December 2019. The kidney is one of the target organs of the causative SARS-CoV-2 virus.The aim of this article is to discuss the current understanding of COVID-19 renal disease from a primary care perspective, with the caveat that our knowledge of the ...
Titus, Thomas, Rahman, Atifur
openaire   +4 more sources